AA
Atharva Ajay Karulkar
About Atharva Ajay Karulkar
Data last updated:
Atharva Ajay Karulkar is a Director at Immunoadoptive Cell Therapy Private Limited (since 2021). The company operates in Healthcare. Immunoadoptive Cell Therapy Private Limited reported revenue of ₹77.75 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Immunoadoptive Cell Therapy Private Limited U74999MH2018PTC315497 | Director | 29 Oct 2021 | 2018 | ₹77.75 Cr (FY 2026) | Active |
Board colleagues of Atharva Ajay Karulkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rahul Purwar | 08251942 | Immunoadoptive Cell Therapy Private Limited | Director |
| Ravindranath Kancherla | 00117940 | Immunoadoptive Cell Therapy Private Limited | Nominee Director |
| Satyanarayana Chava | 00211921 | Immunoadoptive Cell Therapy Private Limited | Nominee Director |
| Shalini Rahul Purwar | 08251943 | Immunoadoptive Cell Therapy Private Limited | Whole-Time Director |
| Shirish Arya | 05356174 | Immunoadoptive Cell Therapy Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Atharva Ajay Karulkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atharva Ajay Karulkar
Atharva Ajay Karulkar currently holds 1 directorship: Immunoadoptive Cell Therapy Private Limited (Director, since 29 Oct 2021, revenue ₹77.75 Cr (FY 2026)).
Atharva Ajay Karulkar was first appointed on 29 Oct 2021 as Director at Immunoadoptive Cell Therapy Private Limited.
The current boards of Atharva Ajay Karulkar's companies include Rahul Purwar (Immunoadoptive Cell Therapy Private Limited), Ravindranath Kancherla (Immunoadoptive Cell Therapy Private Limited), Satyanarayana Chava (Immunoadoptive Cell Therapy Private Limited), Shalini Rahul Purwar (Immunoadoptive Cell Therapy Private Limited), Shirish Arya (Immunoadoptive Cell Therapy Private Limited).